A tool to predict the probability of intracerebral recurrence or new cerebral metastases after whole-brain irradiation in patients with head-and-neck cancer

Christian Staackmann, Stefan Janssen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aim: Patients with metastatic head- and-neck cancer require individual therapies facilitated by prognostic tools. A tool to estimate the risk of recurrent or new cerebral metastases following whole-brain irradiation (WBI) is presented. Patients and Methods: Age, gender, performance status, cancer site, number of cerebral lesions, extracerebral metastases, and time between cancer diagnosis and treatment of cerebral metastases were evaluated for intracerebral control in 23 patients. For characteristics showing a trend (p<0.07), points for these characteristics were created by dividing 6-month intracerebral control rates by 10. Patient scores were obtained by adding these points. Results: Better intracerebral control was significantly associated with oropharyngeal and laryngeal cancer (p=0.014). Absence of extra-cerebral metastases (p=0.069) and longer time between cancer diagnosis and treatment of cerebral metastases (p=0.053) showed trends. Three groups were identified, namely with 3-11, 13-18 and 20-24 points. Six-month intracerebral control rates were 0%, 50% and 100% (p=0.003), respectively, for these groups. Conclusion: A new tool was created to predict intracerebral control following WBI and should contribute to personalization of treatment for patients with cerebral metastases of head-and-neck cancer.

Original languageEnglish (US)
Pages (from-to)4199-4202
Number of pages4
JournalAnticancer Research
Volume38
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Head and Neck Neoplasms
Neoplasm Metastasis
Recurrence
Brain
Oropharyngeal Neoplasms
Neoplasms
Laryngeal Neoplasms
Therapeutics

Keywords

  • Cerebral metastases
  • Head-and-neck cancer
  • Intracerebral recurrence
  • Predictive tool
  • Whole-brain irradiation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A tool to predict the probability of intracerebral recurrence or new cerebral metastases after whole-brain irradiation in patients with head-and-neck cancer. / Staackmann, Christian; Janssen, Stefan; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 38, No. 7, 01.07.2018, p. 4199-4202.

Research output: Contribution to journalArticle

Staackmann, Christian ; Janssen, Stefan ; Schild, Steven E. ; Rades, Dirk. / A tool to predict the probability of intracerebral recurrence or new cerebral metastases after whole-brain irradiation in patients with head-and-neck cancer. In: Anticancer Research. 2018 ; Vol. 38, No. 7. pp. 4199-4202.
@article{169f38bc08d4409f873064ae5e987eed,
title = "A tool to predict the probability of intracerebral recurrence or new cerebral metastases after whole-brain irradiation in patients with head-and-neck cancer",
abstract = "Background/Aim: Patients with metastatic head- and-neck cancer require individual therapies facilitated by prognostic tools. A tool to estimate the risk of recurrent or new cerebral metastases following whole-brain irradiation (WBI) is presented. Patients and Methods: Age, gender, performance status, cancer site, number of cerebral lesions, extracerebral metastases, and time between cancer diagnosis and treatment of cerebral metastases were evaluated for intracerebral control in 23 patients. For characteristics showing a trend (p<0.07), points for these characteristics were created by dividing 6-month intracerebral control rates by 10. Patient scores were obtained by adding these points. Results: Better intracerebral control was significantly associated with oropharyngeal and laryngeal cancer (p=0.014). Absence of extra-cerebral metastases (p=0.069) and longer time between cancer diagnosis and treatment of cerebral metastases (p=0.053) showed trends. Three groups were identified, namely with 3-11, 13-18 and 20-24 points. Six-month intracerebral control rates were 0{\%}, 50{\%} and 100{\%} (p=0.003), respectively, for these groups. Conclusion: A new tool was created to predict intracerebral control following WBI and should contribute to personalization of treatment for patients with cerebral metastases of head-and-neck cancer.",
keywords = "Cerebral metastases, Head-and-neck cancer, Intracerebral recurrence, Predictive tool, Whole-brain irradiation",
author = "Christian Staackmann and Stefan Janssen and Schild, {Steven E.} and Dirk Rades",
year = "2018",
month = "7",
day = "1",
doi = "10.21873/anticanres.12714",
language = "English (US)",
volume = "38",
pages = "4199--4202",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - A tool to predict the probability of intracerebral recurrence or new cerebral metastases after whole-brain irradiation in patients with head-and-neck cancer

AU - Staackmann, Christian

AU - Janssen, Stefan

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background/Aim: Patients with metastatic head- and-neck cancer require individual therapies facilitated by prognostic tools. A tool to estimate the risk of recurrent or new cerebral metastases following whole-brain irradiation (WBI) is presented. Patients and Methods: Age, gender, performance status, cancer site, number of cerebral lesions, extracerebral metastases, and time between cancer diagnosis and treatment of cerebral metastases were evaluated for intracerebral control in 23 patients. For characteristics showing a trend (p<0.07), points for these characteristics were created by dividing 6-month intracerebral control rates by 10. Patient scores were obtained by adding these points. Results: Better intracerebral control was significantly associated with oropharyngeal and laryngeal cancer (p=0.014). Absence of extra-cerebral metastases (p=0.069) and longer time between cancer diagnosis and treatment of cerebral metastases (p=0.053) showed trends. Three groups were identified, namely with 3-11, 13-18 and 20-24 points. Six-month intracerebral control rates were 0%, 50% and 100% (p=0.003), respectively, for these groups. Conclusion: A new tool was created to predict intracerebral control following WBI and should contribute to personalization of treatment for patients with cerebral metastases of head-and-neck cancer.

AB - Background/Aim: Patients with metastatic head- and-neck cancer require individual therapies facilitated by prognostic tools. A tool to estimate the risk of recurrent or new cerebral metastases following whole-brain irradiation (WBI) is presented. Patients and Methods: Age, gender, performance status, cancer site, number of cerebral lesions, extracerebral metastases, and time between cancer diagnosis and treatment of cerebral metastases were evaluated for intracerebral control in 23 patients. For characteristics showing a trend (p<0.07), points for these characteristics were created by dividing 6-month intracerebral control rates by 10. Patient scores were obtained by adding these points. Results: Better intracerebral control was significantly associated with oropharyngeal and laryngeal cancer (p=0.014). Absence of extra-cerebral metastases (p=0.069) and longer time between cancer diagnosis and treatment of cerebral metastases (p=0.053) showed trends. Three groups were identified, namely with 3-11, 13-18 and 20-24 points. Six-month intracerebral control rates were 0%, 50% and 100% (p=0.003), respectively, for these groups. Conclusion: A new tool was created to predict intracerebral control following WBI and should contribute to personalization of treatment for patients with cerebral metastases of head-and-neck cancer.

KW - Cerebral metastases

KW - Head-and-neck cancer

KW - Intracerebral recurrence

KW - Predictive tool

KW - Whole-brain irradiation

UR - http://www.scopus.com/inward/record.url?scp=85049782658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049782658&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12714

DO - 10.21873/anticanres.12714

M3 - Article

C2 - 29970550

AN - SCOPUS:85049782658

VL - 38

SP - 4199

EP - 4202

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -